Physiogenomic analysis links serum creatine kinase activities during statin therapy to vascular smooth muscle homeostasis

Author： Ruaño Gualberto   Thompson Paul D   Windemuth Andreas   Smith Andrew   Kocherla Mohan   Holford Theodore R   Seip Richard   Wu Alan HB  

Publisher： Future Medicine

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.6, Iss.8, 2005-12, pp. : 865-872

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Multiple effects of tyrosine kinase inhibitors on vascular smooth muscle contraction

By Filipeanu C.M.   Brailoiu E.   Huhurez G.   Slatineanu S.   Baltatu O.   Branisteanu D.D.  

European Journal of Pharmacology, Vol. 281, Iss. 1, 1995-07 ,pp. : 29-35

Elsevier

Access to resources Recommend Favorite

Insulin, Thrombin, ERK1/2 Kinase and Vascular Smooth Muscle Cells Proliferation

By  

Current Pharmaceutical Design, Vol. 16, Iss. 35, 2010-12 ,pp. : 3895-3902

Bentham Science Publishers

Access to resources Recommend Favorite

Ethanol inhibits mitogen activated protein kinase activity and growth of vascular smooth muscle cells in vitro

By Hendrickson R.J.   Cahill P.A.   McKillop I.H.   Sitzmann J.V.   Redmond E.M.  

European Journal of Pharmacology, Vol. 362, Iss. 2, 1998-12 ,pp. : 251-259

Elsevier

Access to resources Recommend Favorite

Mitogen-activated protein kinase activity regulation role of angiotensin and endothelin systems in vascular smooth muscle cells

By Kubo T.   Ibusuki T.   Chiba S.   Kambe T.   Fukumori R.  

European Journal of Pharmacology, Vol. 411, Iss. 1, 2001-05 ,pp. : 27-34

Elsevier

Access to resources Recommend Favorite

Phosphatidylinositol 3-kinase in angiotensin II-induced hypertrophy of vascular smooth muscle cells

By Yamakawa T.   Tanaka S.-i.   Kamei J.   Kadonosono K.   Okuda K.  

European Journal of Pharmacology, Vol. 478, Iss. 1, 2003-09 ,pp. : 39-46

Elsevier

Access to resources Recommend Favorite